InvestorsHub Logo

iandy

10/09/17 9:49 AM

#2904 RE: scottsmith #2903

You should have a double by then without a buyout.
They have an upcoming approval early 2018 and the best drug on the market.
All they need is some decent DTC advertising and to announce a head to head trial with Linzess.